Evidence map›Paper›PMID 37152986›Full record

ArticleFrontiers in genetics2023

ONT long-read WGS for variant discovery and orthogonal confirmation of short read WGS derived genetic variants in clinical genetic testing.

Ludmila Kaplun, Greice Krautz-Peterson, Nir Neerman, Christine Stanley, Shane Hussey, Margo Folwick, Ava McGarry, Shirel Weiss, Alexander Kaplun

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. International journal of microbiology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Genetic analysis using long-read sequencing to overcome the difficulties inResearch and practice in thrombosis and haemostasis · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ludmila KaplunVariantyx Inc, Framingham, MA, United States.
Greice Krautz-PetersonVariantyx Inc, Framingham, MA, United States.
Nir NeermanVariantyx Inc, Framingham, MA, United States.
Christine StanleyVariantyx Inc, Framingham, MA, United States.
Shane HusseyVariantyx Inc, Framingham, MA, United States.
Margo FolwickVariantyx Inc, Framingham, MA, United States.
Ava McGarryVariantyx Inc, Framingham, MA, United States.
Shirel WeissVariantyx Inc, Framingham, MA, United States.
Alexander KaplunVariantyx Inc, Framingham, MA, United States.
Science Wares (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological advances in Next-Generation Sequencing dramatically increased clinical efficiency of genetic testing, allowing detection of a wide variety of variants, from single nucleotide events to large structural aberrations. Whole Genome Sequencing (WGS) has allowed exploration of areas of the genome that might not have been targeted by other approaches, such as intergenic regions. A single technique detecting all genetic variants at once is intended to expedite the diagnostic process while making it more comprehensive and efficient. Nevertheless, there are still several shortcomings that cannot be effectively addressed by short read sequencing, such as determination of the precise size of short tandem repeat (STR) expansions, phasing of potentially compound recessive variants, resolution of some structural variants and exact determination of their boundaries,

Indexed as

clinical genetic testinglong read sequencingorthogonal variant confirmationoxford nanopore technologies (ONT)small sequence changes (SSCs)structural variants (SVs)whole genome sequencing (WGS)

Identifiers

PMID37152986
PMCPMC10160624
OpenAlexW4366774494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.